Table 2.
Summary of identified promoters across five tissues
| Tissue | Known promoters |
Novel promoters |
Total | |||||
|---|---|---|---|---|---|---|---|---|
| Protein-coding | Non-coding | Both | Protein-coding | Non-coding | Both | Unassigned | ||
| Brain | 11 611 | 3873 | 207 | 6274 | 152 | 27 | 4241 | 21 926 |
| Kidney | 11 141 | 3520 | 217 | 5729 | 153 | 25 | 3520 | 20 301 |
| Liver | 9441 | 2421 | 114 | 3889 | 104 | 21 | 2322 | 15 720 |
| Lung | 12 020 | 3259 | 187 | 6375 | 169 | 37 | 4033 | 21 599 |
| Spleen | 7163 | 1492 | 63 | 2742 | 70 | 3 | 1638 | 11 401 |
| Total number of non-redundant promoters identified | 38 639 | |||||||
The breakup of Pol-II bound promoters in each tissue is provided as known and novel promoters and their assignment to either protein coding or/ and non-coding genes is indicated.